Navigation Links
Sunesis Receives Approval for Listing on The NASDAQ Capital Market
Date:7/30/2009

ions to improve the lives of people with cancer. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.

SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.

This press release contains forward-looking statements, including without limitation statements related to the effective date of transfer of Sunesis' common stock to The NASDAQ The Capital Market and Sunesis compliance with The NASDAQ Capital Markets' continued listing requirements. Words such as "will" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Sunesis' current expectations. Forward-looking statements involve risks and uncertainties. Sunesis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the risk that Sunesis fails to comply with the continued listing requirements of The NASDAQ Capital Market and that Sunesis may be subject to delisting proceedings in the future. These and other risk factors are discussed under "Risk Factors" and elsewhere in Sunesis' Quarterly Report on Form 10-Q for the quarter ended June 30, 2009 and other filings with the Securities and Exchange Commission. Sunesis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

    Investor Contact:                          Media Contact:
    Sunesis Pharmaceuticals, Inc.              Sunesis Pharmaceuticals, Inc.
    Eric Bjerkholt   
'/>"/>
SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
2. Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
3. Sunesis Pharmaceuticals to Report Third Quarter 2007 Financial Results
4. Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development
5. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
6. Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Womens Cancer
7. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
8. Sunesis Pharmaceuticals to Report Financial Results for the First Quarter on May 8, 2008
9. Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
10. Sunesis Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
11. Sunesis to Present at Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... have developed a technique for controlling the surface tension ... the door to a new generation of reconfigurable electronic ... the fact that the oxide "skin" of the metal ... as a surfactant, lowering the surface tension between the ... a liquid metal alloy of gallium and indium. In ...
(Date:9/15/2014)... idea of fibers made of carbon nanotubes is neat, but ... The single-walled carbon nanotubes in new fibers created at Rice ... process designed by chemist Angel Mart and his colleagues. , ... results this month in the journal ACS Nano , ... together into a fiber. , Left to their own devices, ...
(Date:9/15/2014)... Bioptigen announced today the availability ... the optical device metrology and pre-clinical ophthalmic research markets. ... for Contact Lens Metrology is designed for non-destructive, non-contact, ... lens, IOL structures, and donor tissues. The ... immersed in a hydration bath (saline), automated segmentation of ...
(Date:9/15/2014)...  iVinci Health LLC, the company behind the healthcare ... branded as VisitPay®, has successfully closed $5 million in ... a new extension to VisitPay® – an online Payment ... way for patients to manage their medical bills and ... their families. The new round of funding, ...
Breaking Biology Technology:Researchers control surface tension to manipulate liquid metals 2Rice rolls 'neat' nanotube fibers 2Rice rolls 'neat' nanotube fibers 3Bioptigen Introduces Deep Imaging OCT System for Contact Lens Metrology 2iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 2iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 3
... model, said Christopher Kuhl, CEO and founder of Kuhlfusion. ... business executive from facility and resources standpoints. , ... hub for the growing number of individuals and organizations ... Diverse members of the tech field ranging from freelance ...
... dont even exist at many of their residences, tribal ... to be wired by Motorola Canopy , the ... could be the most underserved communities in need of ... high-speed Internet access for its residents and students, tribal ...
... MADISON, Wis. - This Thursday, the 17th annual SBIR/STTR ... Technology Awards Banquet at the Crowne Plaza in Madison, ... of the Small Business Innovation Research (SBIR) and Small ... access the $1.5 billion federal dollars available to small ...
Cached Biology Technology:IT Fusion to Enhance Milwaukees Entrepreneurial IT Climate 2Motorola Canopy Wires Indian Reservations 2Annual Conference Honors Tech Grant Winners 2
(Date:9/15/2014)... allow us to better understand how the fish ... and provide the type of environmental data to ... siting of protected areas," said Paula Whitfield, a ... Ocean Science (NCCOS) and lead author of the ... the temperate-tropical transition zone, where historically, both temperate ...
(Date:9/15/2014)... the Department of Science and Technology in Society in ... Virginia Tech, has won a 2014 National Science Foundation ... and problems of creating a global nuclear emergency response ... Nuclear Power Plant in March 2011 was a turning ... Schmid said. Three of the plant,s six nuclear reactors ...
(Date:9/15/2014)... For multicellular lifeplants and animalsto thrive in the ... the water. In certain coastal areas, extreme oxygen-starvation ... destroy food web structure. As dissolved oxygen levels ... life into microbial community metabolism resulting in impacts ... , Over the past 50 years, oxygen minimum ...
Breaking Biology News(10 mins):Study finds warming Atlantic temperatures could increase range of invasive species 2'Nuclear disasters don't respect national boundaries' 2Decoding virus-host interactions in the oxygen-starved ocean 2Decoding virus-host interactions in the oxygen-starved ocean 3Decoding virus-host interactions in the oxygen-starved ocean 4Decoding virus-host interactions in the oxygen-starved ocean 5
... centuries, seafarers were plagued by wood-eating gribble that destroyed ... on wooden piers and docks in coastal communities. ... Sustainable Bioenergy Centre at the Universities of York and ... the apparently indigestible. , By examining genes that ...
... Spanish . , Geraniums may hold the key ... 300 plant species and costs the ornamental plant industry $450 ... Agricultural Research Service (ARS). The beetle, Popillia ... plants, including ornamentals, soybean, maize, fruits and vegetables. But within ...
... could substantially reduce the expense of costly treatments ... or bacterial cells by growing these human therapeutic ... have recently gained attention for their ability to ... study, published online this week in Plant Biotechnology ...
Cached Biology News:Seafarers' scourge provides hope for biofuel future 2Geraniums could help control devastating Japanese beetle 2Study shows potential for using algae to produce human therapeutic proteins 2Study shows potential for using algae to produce human therapeutic proteins 3Study shows potential for using algae to produce human therapeutic proteins 4
...
... Varian 500-MS LC Ion Trap is ... LC/MS analysis where sensitivity, reliability and ... provides a robust platform for demanding ... resolution, and mass stability reflect the ...
... This modular benchtop fume hood ... allowing safe indoor release of ... most organic contaminants. Configurations are ... flow; options include final HEPA ...
... for biological safety labs (BSL) and ... Class 10/ISO 3) and easy sterilization. ... surfaces that are easy to wipe ... simplify cleaning. Unique double-wall panel design ...
Biology Products: